Newsletter | June 2, 2020

06.02.20 -- Considerations In Packaging And Delivery Of Clinical Trial Material

Reasons For Building An Approved Phrase Library

The challenge of creating labels for investigational drugs is mounting as more countries sign on to participate in clinical trials. Delays in translating and approving clinical labels can prevent clinical trials from starting on time and threaten to derail development timelines. This e-book discusses the challenges of translating and approving label text and how an approved phrase library can reduce label timelines, improve quality, and assure regulatory compliance.

Clinical Trial Packaging: Smart Choices Can Trim Timelines

Establishing an efficient drug packaging strategy for a clinical trial is not often recognized as a potential timesaver, but it should be. A well thought out packaging strategy can significantly cut your clinical trial timelines and increase the likelihood of a successful trial.

What Clinical Teams Should Know About The Benefits Of Auto-Injectors

For a host of reasons, auto-injectors are becoming biopharma companies’ delivery method of choice for commercial use and late-stage clinical trials. Auto-injectors ensure that the prescribed dose of medication is delivered fully and completely making it easier to track compliance in clinical trials.

Meeting Patient Needs Through Expedited Delivery Of Phase I Materials

The pressure of delivering safe and effective drugs to patients whose quality of life depends on it is compounded by the need to do so in a timely manner. To quickly deliver their product to patients in need, Reneo Pharma found a partner to provide both product development and clinical packaging services.